Clinical Trial Update: A Study of IBI311 in Subjects With Inactive or Active Thyroid Eye Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating IBI311 in patients with Thyroid Eye Disease has completed. The update notes the study status but does not include efficacy r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• IBI311

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Thyroid Eye Disease | Phase 2 | Status: COMPLETED